MyFinsight
Home
About
Contact
glue: the income statement
Download
Download image
Comprehensive (loss) income
-$26,955K
(-14.65%↓ Y/Y)
Unrealized gain (loss) on
available-for-sale securities
$73K
Provision for pension
benefit obligation
$53K
(43.24%↑ Y/Y)
Net (loss) income
-$27,081K
(-13.50%↓ Y/Y)
Income tax benefit
(provision)
-$3,177K
(-4574.65%↓ Y/Y)
Interest income
$2,746K
(-5.05%↓ Y/Y)
Net (loss) income
before income taxes
-$30,258K
(-27.20%↓ Y/Y)
Total other income
$2,717K
(-0.80%↓ Y/Y)
Foreign currency
exchange (loss) gain, net
-$29K
(81.05%↑ Y/Y)
Loss from operations
-$32,975K
(-24.31%↓ Y/Y)
Collaboration revenue
$12,768K
(38.54%↑ Y/Y)
Total operating
expenses
$45,743K
(27.98%↑ Y/Y)
General and
administrative
$9,065K
(11.54%↑ Y/Y)
Research and development
$36,678K
(32.81%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE)